Study on statistical methods to integrate high-dimensional and heterogenous biomedical data for predicting and controlling disease progression
Project/Area Number |
18H03329
|
Research Category |
Grant-in-Aid for Scientific Research (B)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Review Section |
Basic Section 62010:Life, health and medical informatics-related
|
Research Institution | Aichi Cancer Center Research Institute (2019-2020) The University of Tokyo (2018) |
Principal Investigator |
Yamaguchi Rui 愛知県がんセンター(研究所), システム解析学分野, 分野長 (90380675)
|
Co-Investigator(Kenkyū-buntansha) |
横山 和明 東京大学, 医科学研究所, 助教 (00647498)
|
Project Period (FY) |
2018-04-01 – 2021-03-31
|
Project Status |
Completed (Fiscal Year 2020)
|
Budget Amount *help |
¥13,000,000 (Direct Cost: ¥10,000,000、Indirect Cost: ¥3,000,000)
Fiscal Year 2020: ¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2019: ¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
|
Keywords | 病態予測 / 情報統合 / 異種多次元データ / 異種情報統合 / 有用情報抽出 / 微小残存病変 / 変異検出 / 病態遷移モデル / 個別変異データ / スパースモデリング / 病態予測モデル |
Outline of Final Research Achievements |
In this research project, we studied computational methodologies to extract useful information from heterogeneous and multi-dimensional biomedical data from each patient in order to predict and control disease progression. We proposed a new method to integrate Bayes Factors from multiple models. Using that, we can build an accurate somatic mutation caller for multiple samples within a single patient. We also devised an explainable AI to extract useful information from the complex biomedical data such as networks. In addition, we monitored circulating tumor DNAs (ctDNAs) to identify minimal residual diseases (MRDs) for blood cancer patients. We showed ctDNA is useful for predicting disease progression of blood cancers. We are continuing to make a method combining ctDNA and other biomedical data for more accurate prediction of disease progression.
|
Academic Significance and Societal Importance of the Research Achievements |
技術の進展により、患者一人ひとりから多種多様な生体データの情報が得られるようになりつつある。本研究では、それらの異種かつ多要素の膨大なデータを統合的に活用し、個人ごとに異なる病態の経過を、予測しかつ制御するための情報を抽出する数理的方法論を構築することを目標とした。その結果、新たな情報統合および情報抽出のための手法を複数開発した。また実際の臨床データの計測と解析から腫瘍由来循環DNAが血液がんの病態の進展の予測に有用である知見も得た。これらの知見は、今後の更なる精緻な病態遷移予測モデルの開発につながることが期待される。
|
Report
(4 results)
Research Products
(30 results)
-
-
-
-
-
-
[Journal Article] Successful clinical sequencing by molecular tumor board in an elderly patient with refractory Sezary syndrome2020
Author(s)
Hijikata K, Yokoyama K (co-1st and co-corresponding author), Yokoyama N, Matsubara Y, Shimizu E, Nakashima M, Yamagishi M, Ota Y, Lim L, Yamaguchi R, Ito M, Tanaka Y, Denda T, Tani K, Yotsuyanagi H, Imoto S, Miyano S, Uchimaru K, Tojo A.
-
Journal Title
JCO Precis Oncol
Volume: 4
Issue: 4
Pages: 534-560
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] An Unusually Short Latent Period of Therapy-Related Myeloid Neoplasm Harboring a Rare MLL-EP300 Rearrangement: Case Report and Literature Review2019
Author(s)
Takeda R, Yokoyama K (corresponding author), Kobayashi S, Kawamata T, S Nakamura, Tomofusa F, Ito M, Yusa N, Shimizu E, Ohno N, Yamaguchi R, Imoto S, Miyano S, Uchimaru K, and Tojo A.
-
Journal Title
Case Rep Hematol
Volume: epub
Pages: 4532434-4532434
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Prognostic impact of circulating tumor DNA status post-allogeneic hematopoietic stem cell transplantation in AML and MDS.2019
Author(s)
Nakamura S, Yokoyama K (co-1st and co-corresponding author), Shimizu E, Yusa N, Kondoh K, Ogawa M, Takei T, Kobayashi A, Ito M, Isobe M, Konuma T, Kato S, Kasajima R, Wada Y, Inoue-Nagamura T, Yamaguchi R, Takahashi S, Imoto S, Miyano S, and Tojo A.
-
Journal Title
Blood
Volume: 133
Issue: 25
Pages: 2682-2695
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] The first case of elderly TCF3-HLF-positive B-cell acute lymphoblastic leukemia.2019
Author(s)
Takeda R, Yokoyama K (corresponding author), Ogawa M, Kawamata T, Tomofusa F, Kondoh K, Tomomi T, Nakamura S, Ito M, Yusa N, Shimizu E, Ohno N, Uchimaru K, Yamaguchi R, Imoto S, Miyano S, and Tojo A.
-
Journal Title
Leuk lymphoma.
Volume: 60
Issue: 11
Pages: 2821-2824
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
-
-
[Journal Article] Circulating tumor DNA dynamically predicts response and/or relapse in patients with hematological malignancies2018
Author(s)
Nakamura S, Yokoyama K, Yusa N, Ogawa M, Takei T, Kobayashi A, Ito M, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Miyano S, Tojo A
-
Journal Title
Int J Hematol
Volume: 108(4)
Issue: 4
Pages: 402-410
DOI
Related Report
Peer Reviewed
-
-
-
-
-
-
-
[Presentation] 治療関連骨髄系腫瘍15例のゲノム解析と液体生検によるファウンダークローンの後方視的追跡2019
Author(s)
近藤 幹也, 横山 和明, 遊佐 希, 伊藤 美香, 清水 英悟, 中村 聡介, 小川 弥穂, 武井 智美, 小林 麻子, 笠島 理加, 和田 結花, 山口 類, 井元 清哉, 長村 登紀子, 内丸 薫, 宮野 悟, 東條 有伸
Organizer
日本血液学会学術集会
Related Report
-
[Presentation] 臨床シークエンスにて確定診断に至った慢性好中球性白血病の2例2019
Author(s)
小川 弥穂, 横山 和明, 塚田 信弘, 余語 孝夫3, 近藤 幹也, 武井 智美, 中村 聡介, 伊藤 美香, 小林 麻子, 遊佐 希, 山本 茉子, 笠島 理加, 清水 英悟, 山口 類, 井元 清哉, 宮野 悟, 東條 有伸
Organizer
日本血液学会学術集会
Related Report
-
-
[Presentation] The utility of exome sequence of circulating tumor DNA in drug-resistant and/or advanced phase chronic myeloid leukemia2019
Author(s)
Tomomi Takei, Kazuaki Yokoyama, Sousuke Nakamura, Miho Ogawa, Kanya Kondoh, Eigo Shimizu, Rika Kasajima, Rui Yamaguchi, Seiya Imoto, Satoru Miyano, Arinobu Tojo
Organizer
日本癌学会学術総会
Related Report
-
[Presentation] Circulating tumor DNA predicts post-allogeneic hematopoietic stem cell transplantation in AML and MDS2019
Author(s)
Nakamura S, Yokoyama K, Shimizu E, Yusa N, Ogawa M, Takei T, Kobayashi A, Ito M, Isobe M, Konuma T, Kato S, Kasajima R, Wada Y, Nagamura-Inoue T, Yamaguchi R, Takahashi S, Imoto S, Miyano S, Tojo A
Organizer
Molecular Med Tri-Con
Related Report
Int'l Joint Research
-
[Presentation] Prognostic Impact of Circulating Tumor DNA Status Post-Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia and Myelodysplastic Syndrome2018
Author(s)
Nakamura S, Yokoyama K, Shimizu E, Yusa N, Kondoh K, Ogawa M, Takei T, Kobayashi A, Ito M, Isobe M, Konuma T, Kato S, Kasajima R, Wada Y, Inoue-Nagamura T, Yamaguchi R, Takahashi S, Imoto S, Miyano S, Tojo A
Organizer
60th ASH Annual Meeting
Related Report
Int'l Joint Research
-
[Presentation] Residual circulating tumor DNA status in relapse prediction post allogeneic hematopoietic stem cell transplantation2018
Author(s)
Nakamura S, Yokoyama K, Yusa N, Kondo K, Ogawa M, Takei T, Kobayashi A, Ito M, Jimbo K, Tanoue S, Isobe M, Konuma T, Kato S, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Takahashi S, Miyano S, Tojo A
Organizer
第13回生命医科学研究所ネットワーク国際シンポジウム
Related Report
Int'l Joint Research
-
[Presentation] 腫瘍由来循環DNAを用いたAMLおよびMDSの移植後微小残存病変の検出に関する後方視的解析2018
Author(s)
Nakamura S, Yokoyama K, Yusa N, Kondo K, Ogawa M, Takei T, Kobayashi A, Ito M, Jimbo K, Tanoue S, Isobe M, Konuma T, Kato S, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Takahashi S, Miyano S, Tojo A
Organizer
第80回日本血液学会学術総会
Related Report
-
-
-
-
[Presentation] Impact of residual circulating tumor DNA status post allogeneic hematopoietic stem cell transplantation on outcome in acute myeloid leukemia and myelodysplastic syndrome2018
Author(s)
Nakamura S, Yokoyama K, Yusa N, Kondo K, Ogawa M, Takei T, Kobayashi A, Ito M, Jimbo K, Tanoue S, Isobe M, Konuma T, Kato S, Shimizu E, Kasajima R, Wada Y, Yamaguchi R, Imoto S, Nagamura-Inoue T, Takahashi S, Miyano S, Tojo A
Organizer
45th IMSUT Founding Commemorative Symposium
Related Report